Prenetics Global Limited - PRE Net Assets per Single Share

Graphic logo of Prenetics (PRE)

Prenetics Global (PRE) faces significant pressure as it balances biometric data protection requirements between China and the West. This chart of the market valuation helps track these risks, with the indicator currently standing at 5.52. The business is scaling through the implementation of early oncology diagnostic systems and the expansion of B2B partnerships. Production capacities in the UK and Hong Kong ensure leadership within the preventive sector.

PRE: Prenetics Global Ltd Net Asset Value per Share 04/28/2023 - 10/27/2026

Prenetics Global Limited - analytical breakdowns and key metrics (PRE)

- price and consensus price forecast:
Stock Price Prenetics Global Ltd|PRE - Average Forecast Price
- market capitalization data:
Market Value Prenetics Global|PRE - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Prenetics|PRE - Total Stockholders' Equity|Market Capitalization to Book Value Ratio prenetics.com|PRE - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Prenetics Global|PRE - Long-Term Debt to Capital|Short-Term Debt to Equity Prenetics Global Ltd|PRE - Company Aggregate Debt|Debts to Book Capitalization Prenetics Global
Analysis of all company metrics:prenetics.com (PRE)
Manufactured products of Prenetics Global Ltd

The high barrier to entry in the biodata sector and the patent protection of Prenetics Global (PRE) molecular diagnostics create a significant capital asset base. By analyzing the bps metric, an investor can see the net equity value per share minus liabilities, which allows for the determination of the business's real value and the identification of a fundamental discount or the risk of overpayment relative to market quotes.

Competitor analysis for Prenetics Global

A (Agilent Tech) - Book Value per Share|DGX: Net Asset Value per Share|ILMN (Illumina, Inc.) - Net Assets per Single Share|exactsciences.com (EXAS) - Accounting Value per Share|Book Value per Share RVTY (Revvity)|Net Asset Value per Share Bio-Rad Laboratories, Inc.|Book Value per Share Anbio Tech NNNN|Equity per Share Nordion (SHC)|Book Value per Share QDEL (QuidelOrtho)|opko.com - Book Value per Share|CareDx, Inc (CDNA) - Net Assets per Single Share|MRVI - Equity per Share|FLGT: Book Value per Share|LAB (Standard BioTools Corp) - Book Value per Share|Net Assets per Single Share Cytek Biosciences, Inc.|Net Assets per Single Share orasure.com (OSUR)|Exagen Inc. - Accounting Value per Share|Net Asset Value per Share MDXH (MDxHealth S.A.)|Net Assets per Single Share LUCD|Net Assets per Share Insight Molecular Diagnostics, Inc. IMDX|Book Value per Share TRIB (Trinity Biotech Corp)|PRPH: Net Assets per Share|Ainos - Net Assets per Single Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|Net Assets per Single Share Heart Test Laboratories Inc. HSCS|Share Book Value BMRA|Cardio Diagnostics (CDIO) - Net Assets per Single Share|Accounting Value of a Share viraxbiolabs.com (VRAX)|BJDX: Book Value per Share|Aspira Women's Health, Inc. - Net Asset Value per Share|Accelerate Diagnostics, Inc (AXDX) - Net Assets per Single Share|CNTG - Equity per Share|Book Value per Share ENZ|Net Asset Value per Share Fresh2 Group|Genetic Technologies Ltd (GENE) - Accounting Value per Share|Book Price of a Share 23andMe Holding Co|PMD (Psychemedics Corp) - Book Value per Share